Brian Bewley is an accomplished healthcare fraud and abuse attorney with years of experience helping clients navigate the complex regulatory landscape. Brian advises a range of healthcare clients, including for-profit, not-for-profit and private equity, on a myriad of regulatory compliance issues and helps navigate government and internal investigations to help find equitable solutions. Specifically, Brian has successfully defended several healthcare clients in False Claims Act (FCA), civil monetary penalty and exclusion investigations, as well as with audits conducted by the Office of Inspector General-Office of Audit Services and the Centers for Medicare and Medicaid Services (CMS). He has obtained several declinations and dismissals of FCA qui tam matters or has negotiated a settlement of these matters on terms more favorable to his clients.
In addition to advising on government investigations, Brian also advises buyers and sellers, including private equity firms, in healthcare transactions on complex compliance and operational considerations, including compliant joint venture structures, successor liability, pre-closing compliance resolution, post-closing disputes, and voluntary disclosures. His clients are diverse and consist of hospitals and health systems, medical device companies, home health providers, hospice organizations, ambulatory services, post-acute care, specialty-pharmacies, pharmacy benefit managers, and private equity and portfolio companies.
Health Care Compliance Association — Midwest Region Conference, Program Chair (2013-2017)
American Health Lawyers Association (AHLA) — Fraud & Abuse Practice Group, Advisory Opinion Task Force
American Bar Association — Health Law Practice Group
Successfully represented a private equity backed portfolio provider and its management company in a voluntary disclosure to HHS-OIG involving improper billing
Counsel to a private equity investment firm related to the financing of a complex buyout and restructuring of a company providing physician management and radiation oncology management services and cancer centers
Lead regulatory counsel to a private equity investment firm in its multi-billion dollar bid to take a publicly traded healthcare company private
Lead counsel for a large long-term care company named as a defendant in a FCA qui tam action involving allegations of medically unnecessary services and improper billing
Nashville Medical News “InCharge Healthcare” (2017-2020)
Super Lawyers — “Rising Star” (2014)
Inspector General Exceptional Achievement Award (2009-2012)
U.S. Attorney General Honors Attorney (2004)
Washington University Law Review — Executive Notes Editor